PhaseRx

company

About

PhaseRx is a startup company focused on the delivery of siRNA and other macromolecular therapeutics for the treatment of orphan diseases.

  • 11 - 50

Details

Last Funding Type
Series A
Last Funding Money Raised
$20.21M
Industries
Biotechnology,Health Care,Therapeutics
Founded date
Jan 1, 2006
Number Of Employee
11 - 50
Operating Status
Active

PhaseRx is a startup company based in Seattle focused on the delivery of siRNA and other macromolecular therapeutics. The Company has attracted top-tier venture investors and was founded by its President, Robert Overell, Patrick Stayton and Allan Hoffman of the University of Washington, Oliver Press of Fred Hutchinson Cancer Research Center, and Paul Johnson, the Company's Chief Scientific Officer. PhaseRx was conceived on the basis of using novel polymer technology to deliver siRNA. The Company believes the technology also has significant applications for the delivery of other macromolecular therapeutics.

Funding Rounds

Number of Funding Rounds
Total Funding Amount
1
$20.21M
PhaseRx has raised a total of $20.21M in funding over 2 rounds. Their latest funding was raised on Feb 28, 2008 from a Series A round.
Announced Date Round Money Raised Number of Investors Lead Investors Post Valuation
Feb 28, 2008 Series A $20.21M 2 ARCH Venture Partners
Versant Ventures
Detail

Investors

Number of Lead Investors
Number of Investors
2
2
PhaseRx is funded by 2 investors. ARCH Venture Partners and Versant Ventures are the most recent investors.
Investor Name Lead Investor Funding Round
ARCH Venture Partners Yes Series A
Versant Ventures Yes Series A